Altogether, these results point out to a more mature and differentiated tumor pDC, blocked at a stage where the pDC precursor already leaves the BM via PB, with a greater migration capacity into peripheral tissues and secondary lymphoid tissues, which translates into frequent extramedullary organ involvement. The gene discussed is PDC; the disease is neoplasm.